Where is ChemLex located?

ChemLex is headquartered in Shanghai, China.

Who is the current CEO of ChemLex?

Sean Lin of ChemLex. They have also founded 1 company.

How many employees does ChemLex have?

As of Aug 31, 2026, the latest employee count at ChemLex is 36.

Is ChemLex a funded company?

ChemLex is a funded company, having raised a total of $71M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jan 09, 2024.

When was the latest funding round of ChemLex?

ChemLex's latest funding was a $***** Series B round on Dec 08, 2025, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In China, the Biopharma Outsourcing sector has seen $50.6M in funding in 2026 to date.

Where does ChemLex rank among its competitors?

ChemLex ranks 3rd amongst 235 active competitors, of which 21 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was ChemLex, which secured $45M in Dec, 2025.

Who are the top competitors of ChemLex?

ChemLex's top competitors include Sai Life Sciences, NFIL and IRBM. Among them, ChemLex secured the most recent funding round in December, 2025.

ChemLex - 2026 Company Profile, Team, Funding & Competitors

ChemLex is a series B company based in Shanghai (China), founded by Sean Lin. It operates as a Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis. ChemLex has raised $71M in funding from investors like Qiming Venture Partners, Granite Asia and LYFE Capital. The company has 235 active competitors, including 21 funded and 31 that have exited. Its top competitors include companies like Sai Life Sciences, NFIL and IRBM.

Company Details

ChemLex is a knowledge-based company that focuses on closed-loop collaborative research and development through artificial intelligence chemical synthesis path planning and high-throughput. They offer comprehensive consulting services in the field of chemical legislation and plant protection products.

Key Metrics

Location

Shanghai, China

Stage

Series B

Total Funding

$71M in 2 rounds

Latest Funding Round

Series B, Dec 08, 2025, $*****

Investors

Qiming Venture Partners & 4 more

Ranked

3^rd among 235 active competitors

Employee Count

36 as on Aug 31, 2026

Similar Companies

Sai Life Sciences & 272 more

View ChemLex's full profile

ChemLex has raised a total funding of $71M over 2 rounds. Its first funding round was on Jan 09, 2024. Its latest funding round was a Series B round on Dec 08, 2025 for $*****. 1 investor participated in its latest round. ChemLex has 5 institutional investors.

Here is the list of recent funding rounds of ChemLex:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 08, 2025	2257202	Series B	5356076	1764807	8265967	4907565
Jan 09, 2024	9050454	Series A	9285191	2243850	Qiming Venture Partners & 1 more	Sinovation Ventures & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of ChemLex's funding rounds and investors

The founders of ChemLex is Sean Lin. Sean Lin is the CEO of ChemLex.

Here are the details of ChemLex's key team members:

Sean Lin: Founder & CEO of ChemLex.

View details of ChemLex's Founder profiles and Board Members

ChemLex's employee count trend

ChemLex has 36 employees as of Aug 26. Here is ChemLex's employee count trend over the years:

Uncover ChemLex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ChemLex include Sai Life Sciences, NFIL and IRBM. Here is the list of Top 10 competitors of ChemLex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sai Life Sciences 1999, Hyderabad (India), Public	Provider of drug discovery, development, and manufacturing of complex small molecules	$108M	HBM Healthcare Investments, Sequoia Capital ... & 123 others	66/100
2nd	NFIL 1967, Mumbai (India), Public	CRAMS company specialising in the custom chemical synthesis and manufacturing of fluorinated compounds	-	-	50/100
3rd	ChemLex Shanghai (China), Series B	Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis	$71M	LYFE Capital, Qiming Venture Partners & 3 others	49/100
4th	IRBM 2010, Pomezia (Italy), Funding Raised	Integrated drug discovery and preclinical development service provider	-	BioVaria, Europa	48/100
5th	Medicilon 2004, Pudong (China), Funding Raised	Integrated drug discovery and preclinical development services	-	Spinnotec, Fortune Capital & 1 others	47/100
6th	Bioduro 2005, San Diego (United States), Acquired	Global CRDMO providing integrated drug discovery, development, and manufacturing services	-	BridgeWest Group	45/100
7th	Alzheimer's Drug Discovery 1998, New York City (United States), Funding Raised	Foundation aims to discover drugs to prevent, treat, and cure alzheimer's disease	-	HHS	45/100
8th	48Hour Discovery 2017, Edmonton (Canada), Funding Raised	Developer of molecular discovery platform	-	Edmonton, K-Startup Grand Challenge	44/100
9th	Alfa Chemistry 2015, Ronkonkoma (United States), Unfunded	Supplier of research chemicals, reagents, custom synthesis, and analytical services	-	-	43/100
10th	Vernalis 1999, Wokingham (United Kingdom), Acquired	Drugs for the treatment of cough, asthma, migraine and cancer.	-	Invesco Mutual Fund, Thuja Capital & 4 others	43/100